Moreover, a patient cohort with NASH showed significantly higher hepatic protein expression levels of p53, p21 and p66Shc compared to a group with simple steatosis, which again argues for an increase of p53 signaling in NASH that correlates with its severity. The gene discussed is TP53; the disease is metabolic dysfunction-associated steatohepatitis.